August 30, 2007Current Opinion in Critical Care
Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock
Why the study?
Do percutaneous left ventricular assist devices improve clinical outcomes compared to intraaortic balloon pumps in patients with cardiogenic shock?
Population
Patients with cardiogenic shock
Comparison
Percutaneous left ventricular assist devices vs Intraaortic balloon pump (IABP)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Does not support routine LVAD escalation over IABP; leaves open mortality benefit in cardiogenic shock.
Structured PICO
Do percutaneous left ventricular assist devices improve clinical outcomes compared to intraaortic balloon pumps in patients with cardiogenic shock?
P
Population
Patients with cardiogenic shock
I
Intervention
Percutaneous left ventricular assist devices (TandemHeart and Impella Recover LP system)
C
Comparator
Intraaortic balloon pump (IABP)
O
Outcome
Hemodynamic parameters and clinical outcomes including 30-day mortality
Percutaneous LVADs improve hemodynamics in cardiogenic shock compared to IABP, but their benefit on clinical outcomes like mortality remains unproven and they carry higher complication risks.
Cite This Study
Stephan Windecker (2007) studied this question.